Medico Intercontinental Limited (BOM:539938)
India · Delayed Price · Currency is INR 25.50
+0.65 (2.62%)
At close: Sep 11, 2026
Medico Intercontinental Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 255 | 255 | 355 | 398 | 829 | 189 | |
Market Cap Growth | -31.91% | -28.11% | -10.97% | -51.96% | 339.00% | 126.71% |
Enterprise Value | 720 | 751 | 392 | 409 | 795 | 243 |
Last Close Price | 25.50 | 25.50 | 35.47 | 39.84 | 82.83 | 58.07 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | - | - | 7.01 | 10.09 | 22.99 | 6.10 |
PS Ratio | 0.30 | 0.30 | 0.37 | 0.56 | 1.08 | 0.25 |
PB Ratio | 0.79 | 0.79 | 0.71 | 0.89 | 2.01 | 1.50 |
P/TBV Ratio | 0.78 | 0.78 | 0.72 | 0.91 | 2.07 | 1.64 |
P/FCF Ratio | 2.05 | 2.05 | - | 9.18 | - | 5.19 |
P/OCF Ratio | 1.49 | 1.49 | - | 7.14 | - | 4.91 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.86 | 0.89 | 0.41 | 0.57 | 1.04 | 0.33 |
EV/EBITDA Ratio | 24.00 | 19.67 | 4.55 | 6.58 | 13.77 | 4.56 |
EV/EBIT Ratio | - | - | 5.01 | 6.90 | 14.27 | 4.73 |
EV/FCF Ratio | 5.79 | 6.04 | - | 9.43 | - | 6.68 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 2.08 | 2.08 | 0.34 | 0.11 | 0.12 | 0.69 |
Debt / EBITDA Ratio | 23.17 | 17.57 | 1.97 | 0.78 | 0.82 | 1.64 |
Debt / FCF Ratio | - | 5.40 | - | 1.12 | - | 2.40 |
Net Debt / Equity Ratio | 1.90 | 1.90 | 0.29 | 0.03 | -0.05 | 0.54 |
Net Debt / EBITDA Ratio | 21.11 | 16.01 | 1.71 | 0.24 | -0.36 | 1.29 |
Net Debt / FCF Ratio | - | 4.92 | -1.79 | 0.34 | 0.20 | 1.89 |
Asset Turnover | - | 0.87 | 1.44 | 1.24 | 1.69 | 2.38 |
Inventory Turnover | - | 5.33 | 7.83 | 5.66 | 7.36 | 7.04 |
Quick Ratio | - | 1.03 | 2.79 | 3.00 | 2.59 | 1.47 |
Current Ratio | - | 1.62 | 4.39 | 4.28 | 3.24 | 2.17 |
Return on Equity (ROE) | - | -26.67% | 10.63% | 9.16% | 13.41% | 27.96% |
Return on Assets (ROA) | - | -1.03% | 7.36% | 6.45% | 7.67% | 10.25% |
Return on Invested Capital (ROIC) | -3.95% | -2.03% | 10.27% | 10.06% | 13.85% | 19.77% |
Return on Capital Employed (ROCE) | - | -2.00% | 12.10% | 12.60% | 12.80% | 27.20% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | -15.57% | -12.55% | 14.26% | 9.91% | 4.35% | 16.41% |
FCF Yield | 48.76% | 48.76% | -23.08% | 10.90% | -12.69% | 19.26% |
Dividend Yield | - | - | - | - | 0.12% | - |
Payout Ratio | - | - | - | 2.53% | - | - |
Buyback Yield / Dilution | -0.21% | - | - | -55.51% | -97.92% | - |
Total Shareholder Return | -0.21% | - | - | -55.51% | -97.80% | - |